Drugmakers are opting to delist in order to seek greater management flexibility amid dual pressures of short-term investor scrutiny and government-forced price cuts.
Buyout wave seen among Japan drugmakers after Hisamitsu deal
Published 5 days ago
Source: japantimes.co.jp
Categories
BUSINESS
Related Articles from japantimes.co.jp
2 hours ago
At Driftwood, cocktails flow to the sounds of city pop
3 hours ago
Takaichi and South Korea’s Lee to take ties to ‘new heights’ amid Japan-China rift
3 hours ago
To realize a circular economy, Oji advances recycling, partnerships
3 hours ago
Amphipod species with panda-like coloring discovered in Wakayama
3 hours ago
Saga University to launch faculty focused on science of cosmetics
3 hours ago